stoxline Quote Chart Rank Option Currency Glossary
  
Orgenesis Inc. (ORGS)
0.6809  0.041 (6.36%)    03-01 16:00
Open: 0.6454
High: 0.71
Volume: 169,878
  
Pre. Close: 0.6402
Low: 0.6454
Market Cap: 22(M)
Technical analysis
2024-03-01 4:54:24 PM
Short term     
Mid term     
Targets 6-month :  0.86 1-year :  1
Resists First :  0.74 Second :  0.86
Pivot price 0.48
Supports First :  0.43 Second :  0.25
MAs MA(5) :  0.63 MA(20) :  0.43
MA(100) :  0.53 MA(250) :  0.85
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  81.2 D(3) :  77.3
RSI RSI(14): 75.7
52-week High :  1.6 Low :  0.25
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ ORGS ] has closed below upper band by 12.7%. Bollinger Bands are 112.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.71 - 0.71 0.71 - 0.72
Low: 0.64 - 0.64 0.64 - 0.64
Close: 0.68 - 0.68 0.68 - 0.69
Company Description

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.

Headline News

Thu, 15 Feb 2024
Dakota Gold And 2 Other Stocks Under $3 Insiders Are Buying - Markets Insider

Thu, 01 Feb 2024
Orgenesis Inc Strikes Definitive Deal to Acquire Octomera LLC - TipRanks.com - TipRanks

Thu, 25 Jan 2024
Orgenesis Inc. Secures Acquisition of Octomera LLC - TipRanks.com - TipRanks

Wed, 22 Nov 2023
Analysts Expect Orgenesis Inc. (NASDAQ:ORGS) To Breakeven Soon - Yahoo Finance

Wed, 08 Nov 2023
Orgenesis Inc. (NASDAQ:ORGS) On The Verge Of Breaking Even - Simply Wall St

Mon, 28 Aug 2023
Is Orgenesis (ORGS) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 32 (M)
Held by Insiders 2.79e+007 (%)
Held by Institutions 20.1 (%)
Shares Short 190 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -6.45e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin -90.4 %
Operating Margin -2 %
Return on Assets (ttm) 31.8 %
Return on Equity (ttm) -9 %
Qtrly Rev. Growth 2.775e+007 %
Gross Profit (p.s.) -121.73
Sales Per Share -126.49
EBITDA (p.s.) 0
Qtrly Earnings Growth -1 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -25 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 1.34
Stock Dividends
Dividend 0
Forward Dividend 150910
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android